
|Articles|October 1, 2012
Economic burden of kidney cancer eased by robotics
Adoption of robotic surgery for treatment of kidney cancer has led to a modest increase in the annual volume of partial nephrectomies but a substantial cost savings for care of chronic kidney disease, an economic analysis of a 6-year period suggests.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves tebipenem pivoxil for complicated urinary tract infections
2
Louise Emmett, MD, PhD, highlights early data on 225Ac-PSMA-617 in mCRPC
3
Jenny Guo, MD, discusses outcomes with hemi-HoLEP after pelvic radiation
4
Daniel Eun, MD, on telesurgery, AI, and the future of reconstructive urology
5











